Skip to Content

Shawn Hamidinia, Ph.D. is a registered patent attorney in the firm’s Biotechnology and Chemical Practice Group. Shawn has significant experience in U.S. patent preparation and prosecution, foreign prosecution, and appeals before the Patent Trial and Appeal Board. His practice spans the fields of biologics, vaccines, diagnostics, therapeutic compositions and methods, drug formulation and delivery technologies, gene therapies, stem cells and regenerative medicine, cancer immunotherapies, plant biology, pharmaceuticals, small molecules, and polymer chemistry. Shawn also advises clients on strategic issues, including patent infringement, validity, and freedom to operate analyses.

Prior to joining the firm, Shawn worked as a patent examiner in the recombinant protein art unit and then was a patent associate at a Washington DC area IP law firm.

Experience

  • Patent Attorney – Greenblum and Bernstein, P.L.C. – 2018-Present
  • Patent Attorney – with a Washington DC area IP law firm – 2011-2018
  • Patent Agent – with a west coast IP law firm – 2009-2011
  • USPTO Examiner – 2005-2006 (recombinant proteins)

Professional Associations and Memberships

  • Licensing Executives Society (LES)
  • American Intellectual Property Law Association
  • American Bar Association

Representative Publications

  • Hamidinia, S.A., (2019).  “Court Continue to Clarify What is Patent Eligible Subject Matter”, 15 Journal of Generic Medicines 203-206.
  • Michael Mutter and Shawn Hamidinia, Exposure to enhanced damages after Halo, World Intellectual Property Review, February 2, 2017
  • Michael Mutter and Shawn Hamidinia, Halo: a fresh approach to enhanced damages, World Intellectual Property Review, November 29, 2016
  • Hamidinia, S. A., Erdahl, W. L., Chapman, Taylor, R. W., Steinbaugh, G., Taylor, R. W., and Pfeiffer, D. R., Monensin improves the effectiveness of meso-dimercaptosuccinate when used to treat lead intoxication in rats. Environmental Health Perspectives. 114(4): 484-493, 2006.
  • Hamidinia, S. A., Steinbaugh, G., Taylor, R. W., and Pfeiffer, D. R., Selective transport of Pb2+ and Cd2+ across a phospholipid bilayer by a cyclohexanemonocarboxylic acid-capped 15-crown-5 ether. Journal of Inorganic Biochemistry. 100, 403-412, 2006.
  • Hamidinia, S. A., Tan, B., Erdahl, W. L., Chapman, Taylor, R. W., and Pfeiffer, D. R., The ionophore nigericin transports Pb2+ with high activity and selectivity: A comparison to monensin and ionomycin. Biochemistry. 43, 15956-15965, 2004.
  • Hamidinia, S. A., Shimelis, O. I., Tan, B., Erdahl, W. L., Chapman, C. J., Renkes, G. D., Taylor, R. W., and Pfeiffer, D. R., Monensin mediates a rapid and selective transport of Pb2+. TheJournal of Biological Chemistry. 277(41): 38111-38120, 2002.
  • Hamidinia, S. A., Wang, E., Erdahl, W. L, , Chapman, C. J., Taylor, R. W., and Pfeiffer, D. R., Transport properties of the calcium ionophore ETH-129. Biophysical Journal. 81, 3275-3284, 2001.